1Other quality system
Critical production processes were not validated. Yields and/or the reconciled quantities were not checked at appropriate stages.
Inspection Record
Dermolab Pharma Ltée — Health Canada Inspection Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
2Deviation, CAPA, and investigation
Investigations into deviations, reports, and/or follow-up actions were inadequate.
3Laboratory and QC controls
Test methods were not validated or the method transfer studies were not conducted.
About this record
Extracted automatically from the document of the Health Canada inspection on 2022-05-18. The source is available at the link above.
This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.
Translation and classification are automated and may differ in nuance from the source.
